Antonio Villaverde

发表

Microbial biofabrication for nanomedicine: biomaterials, nanoparticles and beyond.

Esther Vázquez, Antonio Villaverde, E. Vázquez, 2013, Nanomedicine.

Modelling and parameter estimation of gene expression and cell growth in batch cultures

Antonio Villaverde, José Luis Corchero, Rafael Cubarsí Morera, 2000 .

Efficient bioactive oligonucleotide‐protein conjugation for cell‐targeted cancer therapy

Esther Vázquez, Antonio Villaverde, Ramon Eritja, 2019, ChemistryOpen.

A new editorial board for a new editorial period

Antonio Villaverde, 2004, Microbial cell factories.

Engineering building blocks for self-assembling protein nanoparticles

Esther Vázquez, Antonio Villaverde, E. Vázquez, 2010, Microbial cell factories.

Inclusion bodies of fuculose‐1‐phosphate aldolase as stable and reusable biocatalysts

Antonio Villaverde, Elena García-Fruitós, Josep López-Santín, 2012, Biotechnology progress.

Discriminating Foot-and-Mouth Disease Virus-Infected and Vaccinated Animals by Use of β-Galactosidase Allosteric Biosensors

Antonio Villaverde, A. Villaverde, F. Sobrino, 2009, Clinical and Vaccine Immunology.

Protein aggregated into bacterial inclusion bodies does not result in protection from proteolytic digestion

Antonio Villaverde, A. Villaverde, Xavier Carbonell, 2002, Biotechnology Letters.

Functional protein aggregates: just the tip of the iceberg.

Antonio Villaverde, José Luis Corchero, Elena Garcia-Fruitós, 2015, Nanomedicine.

Unconventional microbial systems for the cost-efficient production of high-quality protein therapeutics.

Antonio Villaverde, Markku Saloheimo, Brigitte Gasser, 2013, Biotechnology advances.

Uses of β-galactosidase tag in on-line monitoring production of fusion proteins and gene expression in Escherichia coli

Antonio Villaverde, Javier Lafuente, Francisco Valero, 1993 .

Protein-Based Therapeutic Killing for Cancer Therapies.

Esther Vázquez, Antonio Villaverde, Ugutz Unzueta, 2017, Trends in biotechnology.

Protein-only, antimicrobial peptide-containing recombinant nanoparticles with inherent built-in antibacterial activity.

Esther Vázquez, Antonio Villaverde, Ugutz Unzueta, 2017, Acta biomaterialia.

Role of molecular chaperones in inclusion body formation

Antonio Villaverde, A. Villaverde, M Mar Carrió, 2003, FEBS letters.

The nanoscale properties of bacterial inclusion bodies and their effect on mammalian cell proliferation.

Antonio Villaverde, Neus Ferrer-Miralles, Escarlata Rodríguez-Carmona, 2010, Biomaterials.

Localization of Chaperones DnaK and GroEL in Bacterial Inclusion Bodies

Antonio Villaverde, A. Villaverde, M. Mar Carrió, 2005, Journal of bacteriology.

Nanostructured bacterial materials for innovative medicines.

Antonio Villaverde, Escarlata Rodríguez-Carmona, A. Villaverde, 2010, Trends in microbiology.

Biomedical applications of distally controlled magnetic nanoparticles.

Antonio Villaverde, José Luis Corchero, J. Corchero, 2009, Trends in biotechnology.

Recombinant pharmaceuticals from microbial cells: a 2015 update

Esther Vázquez, Antonio Villaverde, Neus Ferrer-Miralles, 2016, Microbial Cell Factories.

A nanostructured bacterial bioscaffold for the sustained bottom-up delivery of protein drugs.

Antonio Villaverde, Elena García-Fruitós, Matthew J Dalby, 2013, Nanomedicine.

Conformational and functional variants of CD44-targeted protein nanoparticles bio-produced in bacteria

Esther Vázquez, Antonio Villaverde, Oscar Conchillo-Solé, 2016, Biofabrication.

Learning about protein solubility from bacterial inclusion bodies

Antonio Villaverde, Elena García-Fruitós, Mónica Martínez-Alonso, 2009, Microbial cell factories.

Biological role of bacterial inclusion bodies: a model for amyloid aggregation

Antonio Villaverde, Raimon Sabate, Salvador Ventura, 2011, The FEBS journal.

Bacterial inclusion bodies: making gold from waste.

Esther Vázquez, Antonio Villaverde, José Luis Corchero, 2012, Trends in biotechnology.

Microbial factories for recombinant pharmaceuticals

Esther Vázquez, Antonio Villaverde, Neus Ferrer-Miralles, 2009 .

Recombinant protein solubility—does more mean better?

Antonio Villaverde, Elena García-Fruitós, A. Villaverde, 2007, Nature Biotechnology.

Enhanced response to antibody binding in engineered beta-galactosidase enzymatic sensors.

Antonio Villaverde, Neus Ferrer-Miralles, N. Ferrer-Miralles, 2002, Biochimica et biophysica acta.

Protein folding and conformational stress in microbial cells producing recombinant proteins: a host comparative overview

Antonio Villaverde, Markku Saloheimo, Brigitte Gasser, 2008 .

Bacterial Inclusion Bodies: Discovering Their Better Half.

Esther Vázquez, Antonio Villaverde, José Luis Corchero, 2017, Trends in biochemical sciences.

Localization of Functional Polypeptides in Bacterial Inclusion Bodies

Antonio Villaverde, A. Villaverde, E. Garcia-Fruitós, 2006, Applied and Environmental Microbiology.